NOAEL Studies
Cosmetic Ingredient
Lawsone NOAEL Studies
INCI: LAWSONE (2-HYDROXY-1,4-NAPHTHOQUINONE)
CAS: 83-72-7
Raw No Observed Adverse Effect Level endpoint records grouped by source. This page does not render calculated Margin of Safety values.
COSMOS DB 1 endpoint
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| COSMOS DB | LOAEL | 2 | mg/kg bw/day | rat | oral | 91 day | Subchronic | SCCNFP; 13-Week toxicity study by oral route in rats - 2-Hydroxy-1,4-naphthoquinone. CIT, France. Report No: 11312 TCR. 10.4.1995 |
SCCNFP Opinion 8 endpoints
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| SCCNFP Opinion | NOAEL | =0.5 | % | rat | oral | 7 days | NOAEL study | p.8 |
| SCCNFP Opinion | NOAEL | =2 | mg/kg bw/day | rabbit | - | 13- week | irritation | p.2 |
| SCCNFP Opinion | NOAEL | =2 | mg/kg bw/day | rabbit | - | 13-week | irritation | (ref. 5.1), p.8 |
| SCCNFP Opinion | NOAEL | =2 | mg/kg bw/day | - | oral | - | NOAEL study | p.2 |
| SCCNFP Opinion | NOAEL | =7 | mg/kg bw/day | rabbit | - | 13-week | irritation | (ref. 5.1), p.9 |
| SCCNFP Opinion | NOAEL | =20 | mg/kg bw/day | - | - | - | NOAEL study | Ref. : 12, p.12 |
| SCCNFP Opinion | NOAEL | =20 | mg/kg bw/day | human | - | - | dermal absorption | Ref. : 12 2, p.11 |
| SCCNFP Opinion | NOAEL | =300 | mg/kg | rat | dermal | 13-week | dermal absorption | p.19 |
Regulatory source 12 endpoints
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| Regulatory source | - | 0.5 | % | rat | oral | 7 days | - | p.8 |
| Regulatory source | - | 2 | mg/kg bw/day | - | oral | - | - | p.3 |
| Regulatory source | - | 7 | mg/kg bw/day | - | - | - | - | p.12 |
| Regulatory source | - | 20 | mg/kg bw/day | - | - | - | - | p.12 |
| Regulatory source | dermal absorption | 2 | mg/kg bw/day | rat | oral | 13-week | dermal absorption | p.27 |
| Regulatory source | dermal absorption | 7 | mg/kg bw/day | human | - | - | dermal absorption | p.11 |
| Regulatory source | dermal absorption | 20 | mg/kg bw/day | human | - | - | dermal absorption | p.11 |
| Regulatory source | dermal absorption | 300 | mg/kg | rat | dermal | 13-week | dermal absorption | p.19 |
| Regulatory source | irritation | 2 | mg/kg bw/day | rabbit | - | 13- week | irritation | p.2 |
| Regulatory source | irritation | 2 | mg/kg bw/day | rabbit | - | 13-week | irritation | p.9 |
| Regulatory source | irritation | 2 | mg/kg bw/day | rat | - | 13-week | irritation | p.19 |
| Regulatory source | irritation | 7 | mg/kg bw/day | rabbit | - | 13-week | irritation | p.9 |
openFDA substances 1 endpoint
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| openFDA substances | FDA UNII substance identifier | TLH4A6LV1W | UNII | - | - | - | chemical | - |